Exicure, Inc. (NASDAQ:XCUR) Short Interest Update

Exicure, Inc. (NASDAQ:XCUR) was the target of a significant drop in short interest in April. As of April 15th, there was short interest totalling 151,700 shares, a drop of 16.0% from the March 31st total of 180,600 shares. Based on an average daily trading volume, of 213,100 shares, the days-to-cover ratio is currently 0.7 days. Approximately 2.0% of the company’s stock are short sold.

Insider Activity at Exicure

In other Exicure news, major shareholder Co. Ltd. Dgp sold 3,400,000 shares of the firm’s stock in a transaction on Thursday, February 29th. The stock was sold at an average price of $1.32, for a total transaction of $4,488,000.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 3.90% of the stock is owned by company insiders.

Exicure Stock Down 1.7 %

Exicure stock opened at $0.50 on Friday. Exicure has a 12-month low of $0.36 and a 12-month high of $1.50. The business’s 50-day moving average price is $0.61 and its two-hundred day moving average price is $0.60. The stock has a market cap of $4.32 million, a PE ratio of 0.30 and a beta of 1.31.

About Exicure

Exicure, Inc, an early-stage biotechnology company, develops nucleic acid therapies targeting ribonucleic acid against validated targets. The company's preclinical candidate includes SCN9A that is in preclinical studies for the treatment of chronic pain. It also develops immuno-oncology therapeutics based on its proprietary SNA technology.